Natera Inc. Common Stock vs SoundHound AI Inc — how do they compare? Natera Inc. Common Stock trades at $393.93 (market cap $57.03B), while SoundHound AI Inc trades at $4.38 (market cap $2.01B). The key difference: Natera Inc. Common Stock is far larger — about 28.4× SoundHound AI Inc's market cap, and Natera Inc. Common Stock is trading nearer its 52-week high, SoundHound AI Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and SoundHound AI Inc for 24 Days on average.
| NTRA | SOUN | |
|---|---|---|
Market Cap | $57.03B | $2.01B |
Volume | 1,131,157 | 19,541,649 |
Sector | Health | Technology |
52-Week High | $425.64 | $21.40 |
52-Week Low | $179.42 | $4.53 |
Typical Hold Time | 0 Days | 24 Days |
Enterprise Value | $56.18B | $1.81B |
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
SoundHound AI (SOUN) trades at $4.88, down 1.81% on the day, with a bearish technical signal despite bullish oscillators. The company shows strong revenue growth ($169M in 2025, $203M projected for 2026) but deep losses (-$14M net income in 2025). Recent developments include expansion in restaurant and banking sectors with its OASYS Edge technology. Analyst consensus is strongly bullish with a $9.33 price target, representing 91% upside potential from current levels.
While facing significant profitability challenges and negative cash flow trends, SOUN's expanding market footprint and consistent earnings beats create potential for long-term growth. Key risks include integration challenges from acquisitions, high valuation multiples, and ongoing cash burn. The stock offers substantial upside if execution improves but requires careful risk management given current financial metrics.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →